Italy on the Move 2021: round table in the context of J.P. Morgan Annual Healthcare Conference
Modena, Italy, January 14th, 2021 – “Italy on the move”, a new Life science companies networking opportunity, is at the third year edition. The event was at the first time on a digital platform, and happened in the same days of the J.P. Morgan Annual Healthcare Conference.
In the context of a webinar promoted by ICE, the Italian agency for the Foreign promotion and the Italian companies internationalization and the Foreing Affairs Minister, in partnership with Farmindustria and Assobiotech, Holostem and other 8 top italian biotech (Dorian Therapeutics, Europmed Pharma, Geeneta Science, kither, Multiply Labs, Reithera, Sifi e Transactiva), introduced themselves to a Life Sciences investors Group.
Among the round table speaker – the chairman was Jon Carroll, Endopoint news journalist, Armando Varricchio, USA italian ambassador, Manlio Di Stefano, Foreing Affairs and International Cooperation secretary, Carlo Ferro, Italian Trade Agency president, our CEO Marco Dieci, introduced Holostem with a focus on the international market and the new USA investment area.
Present on the European market with Holoclar, the world’s first approved stem cell-based ATMP, Holostem is now looking for a new positioning for its therapy for the reconstruction of the ocular surface damaged by corneal burns and for the products under development, such as gene therapy for Butterfly Children and other epithelial stem cell based therapies.
- Newcastle pharmacy experts work with Italian biotech lab to provide access to sight-saving treatment across England
- Holostem Terapie Avanzate begins its transition to a Foundation
- Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa — 5-Year Outcomes
- Gene therapy for butterfly children: 5-year follow-up published in the New England Journal of Medicine
- Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa